FAA Medical Screening for Space
Medicine as part of the luxury product
A practical, deeply “science of luxury” story is how medicine becomes part of the product when wealthy civilians buy spaceflight. The FAA’s Office of Aerospace Medicine notes that commercial spaceflight is far more hazardous than airline travel, with stressors including acceleration, microgravity, and solar/cosmic radiation.
The Story Angle
The FAA guidance splits passengers into categories: suborbital profiles with up to about +3Gz versus higher‑g or orbital profiles. For suborbital passengers, it recommends a simple medical history questionnaire reviewed by a physician trained in aerospace medicine. For orbital (or >+3Gz) profiles, it recommends a comprehensive history, physical exam, and laboratory testing, valid for one year with an abbreviated update 1–2 weeks before each flight.
It also assumes a cabin pressure not exceeding 8,000 ft, no pressure suit requirement, and passenger capability to perform an emergency evacuation. This creates a new kind of concierge medicine: space‑specific health assessment as part of the ticket purchase.
Why It Matters for Luxury
Space tourism forces a conversation about risk that most luxury experiences avoid. The FAA guidance makes clear this isn't just an expensive plane ride—it's exposure to genuinely novel physiological stresses. Medicine becomes part of the luxury service bundle.
Research
- Guidance for Medical Screening of Commercial Aerospace Passengers (FAA) — Aerospace medicine framework for suborbital vs. orbital profiles (January 2006)
Primary Sources
- FAA Human Space Flight — Operator disclosure requirements and participant responsibilities (August 2025)
- 14 CFR § 460.45 — Operator must inform space flight participants of risk (December 2020)
- Guidance on Informing Crew and Space Flight Participants of Risk (FAA) — Informed consent policy guidance (April 2017)
- AC 460.15-1: Human Factors Considerations in Commercial Human Space Flight — FAA advisory circular on human factors (August 2024)